Hide

FocusBar

Subscribe to Premium Member
Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M72,130Revenue $M123,133Net Margin (%)3.1Z-Score4.4
Enterprise Value $M80,800EPS $3.2Operating Margin %5.9F-Score6
P/E(ttm))19.7Cash Flow Per Share $4.1Pre-tax Margin (%)5.1Higher ROA y-yY
Price/Book1.910-y EBITDA Growth Rate %19.9Quick Ratio0.7Cash flow > EarningsY
Price/Sales0.65-y EBITDA Growth Rate %8.0Current Ratio1.4Lower Leverage y-yY
Price/Cash Flow11.4y-y EBITDA Growth Rate %19.7ROA % (ttm)5.9Higher Current Ratio y-yN
Dividend Yield %1.3Insider Buy (3m)0ROE % (ttm)10.3Less Shares Outstanding y-yN
Payout Ratio %22.2Shares Outstanding M1,231ROI % (ttm)8.8Gross Margin Increase y-yN

Gurus Latest Trades with CVS

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Number of guru portfolios checked: 51.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CVSWarren Buffett 2012-06-30 Reduce-0.11%$43.14 - $46.49
($44.87)
$ 58.9831%Reduce -25.39%5,301,916
CVSPRIMECAP Management 2012-06-30 Reduce-0.02%$43.14 - $46.49
($44.87)
$ 58.9831%Reduce -39.93%543,000
CVSLee Ainslie 2012-03-31 Add1.26%$41.46 - $45.65
($40.41)
$ 58.9846%Add 68.63%4,770,502
CVSRuane Cunniff 2012-03-31 Reduce-0.15%$41.46 - $45.65
($40.41)
$ 58.9846%Reduce -92.58%33,254
CVSLee Ainslie 2011-12-31 Buy 1.6%$32.97 - $41.16
($37.2)
$ 58.9858%New holding, 2828970 sh.2,828,970
CVSWarren Buffett 2011-12-31 Add0.09%$32.97 - $41.16
($37.2)
$ 58.9858%Add 25.53%7,106,500
CVSPRIMECAP Management 2011-12-31 Add0.03%$32.97 - $41.16
($37.2)
$ 58.9858%Add 84.34%883,000
CVSVanguard Health Care Fund 2011-12-31 Add0.02%$32.97 - $41.16
($37.2)
$ 58.9858%Add 50%300,000
CVSLeon Cooperman 2011-12-31 Reduce-0.78%$32.97 - $41.16
($37.2)
$ 58.9858%Reduce -29.34%1,890,255
CVSJohn Paulson 2011-12-31 Sold Out -0.41%$32.97 - $41.16
($37.2)
$ 58.9858%Sold Out0
CVSGeorge Soros 2011-12-31 Sold Out -0.13%$32.97 - $41.16
($37.2)
$ 58.9858%Sold Out0
CVSWallace Weitz 2011-09-30 Add0.49%$32.06 - $38.54
($35.73)
$ 58.9865%Add 34.59%1,163,570
CVSJohn Paulson 2011-09-30 Buy 0.41%$32.06 - $38.54
($35.73)
$ 58.9865%New holding, 2500000 sh.2,500,000
CVSWarren Buffett 2011-09-30 Buy 0.32%$32.06 - $38.54
($35.73)
$ 58.9865%New holding, 5661000 sh.5,661,000
CVSLeon Cooperman 2011-09-30 Add0.22%$32.06 - $38.54
($35.73)
$ 58.9865%Add 9.12%2,675,255
CVSVanguard Health Care Fund 2011-09-30 Buy 0.04%$32.06 - $38.54
($35.73)
$ 58.9865%New holding, 200000 sh.200,000
CVSJoel Greenblatt 2011-09-30 Reduce-0.22%$32.06 - $38.54
($35.73)
$ 58.9865%Reduce -60.96%26,927
CVSJames Barrow 2011-09-30 Reduce-0.18%$32.06 - $38.54
($35.73)
$ 58.9865%Reduce -27.89%6,125,116
CVSGeorge Soros 2011-09-30 Reduce-0.15%$32.06 - $38.54
($35.73)
$ 58.9865%Reduce -54.46%231,735
CVSRuane Cunniff 2011-09-30 Reduce-0.14%$32.06 - $38.54
($35.73)
$ 58.9865%Reduce -46.11%471,250
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CVS is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
CVS Vanguard Health Care Fund 2013-03-311,699,8000.140.37+466.6%
CVS Mario Gabelli 2013-03-311,633,6620.130.57+3.13%
CVS PRIMECAP Management 2013-03-3121,00000
CVS Ruane Cunniff 2013-03-3126,15500.01-0.38%
CVS James Barrow 2013-03-31686,8950.060.07-27%
CVS Joel Greenblatt 2013-03-3160,14400.17-30.68%
CVS Wallace Weitz 2013-03-31557,7000.051.2-32.31%
CVS Ray Dalio 2013-03-31340,4500.030.17-44.46%
CVS John Hussman 2013-03-31000Sold Out
CVS Scott Black 2012-12-31172,6750.011.2New Buy
Premium Most recent portfolio changes are included for Premium Members only!


CVS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Finucane Anne A.Director 2013-04-15Sell500$57.243.04view
Brennan Troyen AEVP, Chief Medical Officer 2013-04-15Sell139,618$57.312.91view
Brennan Troyen AEVP, Chief Medical Officer 2013-03-19Sell34,422$549.22view
PICCOLO C ADirector 2012-12-14Sell98,555$49.1719.95view
Sussman AndrewSVP & President, MinuteClinic 2012-10-04Sell9,020$4920.37view
Bisaccia LisaSVP, Chief HR Officer 2012-10-01Sell56,493$48.4221.81view
Moriarty Thomas MEVP & General Counsel 2012-10-01Buy6,164$48.6721.18view
Joyner J. DavidEVP, Sales & Account Services 2012-09-19Sell33,903$4822.88view
Finucane Anne A.Director 2012-09-17Sell1,000$46.8725.84view
Denton David MEVP, CFO 2012-09-13Sell11,526$4725.49view

Press Releases about CVS:

Quarterly/Annual Reports about CVS:

News about CVS:

Articles On GuruFocus.com
Walgreen Co. (WAG) Dividend Stock Analysis Apr 05 2013 
Chris Davis' Davis New York Venure Fund 2013 Annual Commentary Mar 08 2013 
Early Movers for Feb. 6, 2013 Feb 06 2013 
Delphi Management's Scott Black Releases Fourth Quarter New Stocks Jan 31 2013 
Dividend Contenders in Value for the Accumulation or Income Distribution Phase of the Retirement Por Jan 30 2013 
Steven Romick’s Top Growth Predictable Stocks Jan 22 2013 
My 4 Favorites from the 20 Most Recommended Dividend Stocks at All-Time Highs Jan 19 2013 
My 3 Favorites from the 20 Best Recommended Services Dividend Stocks Jan 12 2013 
Why Is Leon Cooperman Shopping in Walgreen’s? Dec 16 2012 
Tesco to Close or Sell U.S. Stores; Will Warren Buffett Buy More? Dec 05 2012 

More From Our Partners
Green Light for WAG and ABC Deal - Analyst Blog May 20 2013 - ZACKS

Add Notes, Comments or Ask Questions

Comments

No comment yet
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK